ClinicalTrials.Veeva

Menu

Diabetic Retinopathy Screening in General Practice

A

Aalborg University

Status

Completed

Conditions

Type2 Diabetes
Diabetic Retinopathy

Treatments

Diagnostic Test: Diabetic Retinopathy Screening

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark.

The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.

Enrollment

300 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with type 2 diabetes
  • Understands Danish
  • Age between 18-70

Exclusion criteria

  • Blindness
  • Cannot partake in second screening

Trial design

300 participants in 1 patient group

People with type 2 diabetes
Description:
People diagnosed with type 2 diabetes age 18-70
Treatment:
Diagnostic Test: Diabetic Retinopathy Screening

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems